STAT+: Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent
Report from the trade press
Headline as published by STAT on Nov 2, 2026; collected by the wire Nov 2, 2026, 5:00 AM ET.
Coverage
Named in this story
- MDLMDL 3180 · DupixentMatched on
Dupixent
Topics
- Mass torts and MDLsMatched on
Dupixent
Explore the named firms, organizations and MDL dockets above. Sources and method
MDL No. 3180
Dupixent
IN RE: Dupixent (Dupilumab) Products Liability Litigation
- Transferee judge
- Zahid N. Quraishi
- Court
- District of New Jersey
- Actions pending
- 38
Per the JPML pending-dockets report of October 1, 2026.